Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1988 Jul 15;139(2):127–130.

The use of vitamin K in the perinatal period. Fetus and Newborn Committee, Canadian Paediatric Society.

PMCID: PMC1268027  PMID: 3292034

Abstract

The incidence of hemorrhagic disease of the newborn (HDNB) can be expected to increase in Canada as breast-feeding becomes more popular. There are three clinical patterns of hemorrhagic disease: early HDNB (usually related to maternal drug ingestion), classic HDNB (related to breast-feeding) and late hemorrhagic disease of infancy (related to the combination of breast-feeding and diseases that cause fat malabsorption). Despite the knowledge that the disease can virtually be prevented by the administration of vitamin K, not all newborns are being routinely considered for such treatment. The Canadian Paediatric Society has made several recommendations: (a) women who take drugs that interfere with vitamin K1 metabolism should receive oral doses of vitamin K1 daily for a minimum of 2 weeks before expected delivery; (b) all healthy term infants should receive a single dose of vitamin K1, orally or intramuscularly, within 6 hours after birth; (c) all other newborns, including preterm, low-birthweight and sick infants, should receive a single intramuscular dose of vitamin K1 within 6 hours after birth; and (d) infants at high risk for secondary late-onset hemorrhagic disease due to fat malabsorption should receive vitamin K1 orally every day or intramuscularly once a month.

Full text

PDF
127

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABALLI A. J., DE LAMERENS S. Coagulation changes in the neonatal period and in early infancy. Pediatr Clin North Am. 1962 Aug;9:785–817. doi: 10.1016/s0031-3955(16)31311-6. [DOI] [PubMed] [Google Scholar]
  2. Aballi A. J. Vitamin K and the newborn. Lancet. 1978 Jun 24;1(8078):1358–1358. doi: 10.1016/s0140-6736(78)92426-1. [DOI] [PubMed] [Google Scholar]
  3. Behrmann B. A., Chan W. K., Finer N. N. Resurgence of hemorrhagic disease of the newborn: a report of three cases. CMAJ. 1985 Nov 1;133(9):884–885. [PMC free article] [PubMed] [Google Scholar]
  4. CROSSE V. M., MEYER T. C., GERRARD J. W. Kernicterus and prematurity. Arch Dis Child. 1955 Dec;30(154):501–508. doi: 10.1136/adc.30.154.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Corrigan J. J., Jr, Kryc J. J. Factor II (prothrombin) levels in cord blood: correlation of coagulant activity with immunoreactive protein. J Pediatr. 1980 Dec;97(6):979–983. doi: 10.1016/s0022-3476(80)80440-9. [DOI] [PubMed] [Google Scholar]
  6. DAM H., DYGGVE H., LARSEN H., PLUM P. The relation of vitamin K deficiency to hemorrhagic disease of the newborn. Adv Pediatr. 1952 Jan;5:129–153. [PubMed] [Google Scholar]
  7. Deblay M. F., Vert P., Andre M., Marchal F. Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother. Lancet. 1982 May 29;1(8283):1247–1247. doi: 10.1016/s0140-6736(82)92371-6. [DOI] [PubMed] [Google Scholar]
  8. Dunn P. M. Vitamin K1 for all newborn babies. Lancet. 1982 Oct 2;2(8301):770–770. doi: 10.1016/s0140-6736(82)90953-9. [DOI] [PubMed] [Google Scholar]
  9. Frick P. G., Riedler G., Brögli H. Dose response and minimal daily requirement for vitamin K in man. J Appl Physiol. 1967 Sep;23(3):387–389. doi: 10.1152/jappl.1967.23.3.387. [DOI] [PubMed] [Google Scholar]
  10. Haroon Y., Shearer M. J., Rahim S., Gunn W. G., McEnery G., Barkhan P. The content of phylloquinone (vitamin K1) in human milk, cows' milk and infant formula foods determined by high-performance liquid chromatography. J Nutr. 1982 Jun;112(6):1105–1117. doi: 10.1093/jn/112.6.1105. [DOI] [PubMed] [Google Scholar]
  11. Hull M. G., Wilson J. A. Massive scalp haemorrhage after fetal blood sampling due to haemorrhagic disease. Br Med J. 1972 Nov 11;4(5836):321–322. doi: 10.1136/bmj.4.5836.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LEONARD S., ANTHONY B. Giant cephalhematoma of newborn with hemorrhagic disease and hyperbilirubinemia. Am J Dis Child. 1961 Feb;101:170–173. doi: 10.1001/archpedi.1961.04020030034007. [DOI] [PubMed] [Google Scholar]
  13. Lane P. A., Hathaway W. E. Vitamin K in infancy. J Pediatr. 1985 Mar;106(3):351–359. doi: 10.1016/s0022-3476(85)80656-9. [DOI] [PubMed] [Google Scholar]
  14. MEYER T. C., ANGUS J. The effect of large doses of synkavit in the newborn. Arch Dis Child. 1956 Jun;31(157):212–215. doi: 10.1136/adc.31.157.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Malhotra K. K. Care of the newborn in perinatal units in New Brunswick. CMAJ. 1986 May 1;134(9):1009–1011. [PMC free article] [PubMed] [Google Scholar]
  16. Malia R. G., Preston F. E., Mitchell V. E. Evidence against vitamin K deficiency in normal neonates. Thromb Haemost. 1980 Dec 19;44(3):159–160. [PubMed] [Google Scholar]
  17. McNinch A. W., Orme R. L., Tripp J. H. Haemorrhagic disease of the newborn returns. Lancet. 1983 May 14;1(8333):1089–1090. doi: 10.1016/s0140-6736(83)91921-9. [DOI] [PubMed] [Google Scholar]
  18. McNinch A. W., Upton C., Samuels M., Shearer M. J., McCarthy P., Tripp J. H., L'E Orme R. Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child. 1985 Sep;60(9):814–818. doi: 10.1136/adc.60.9.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Motohara K., Endo F., Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet. 1985 Aug 3;2(8449):242–244. doi: 10.1016/s0140-6736(85)90291-0. [DOI] [PubMed] [Google Scholar]
  20. Mountain K. R., Hirsh J., Gallus A. S. Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet. 1970 Feb 7;1(7641):265–268. doi: 10.1016/s0140-6736(70)90636-7. [DOI] [PubMed] [Google Scholar]
  21. O'Connor M. E., Addiego J. E., Jr Use of oral vitamin K1 to prevent hemorrhagic disease of the newborn infant. J Pediatr. 1986 Apr;108(4):616–619. doi: 10.1016/s0022-3476(86)80851-4. [DOI] [PubMed] [Google Scholar]
  22. Ross S. G., Malloy H. T. Blood Prothrombin in the New-born: the Effect of Vitamin K Upon the Blood Prothrombin and Upon Haemorrhagic Disease of the New-Born. Can Med Assoc J. 1941 Nov;45(5):417–421. [PMC free article] [PubMed] [Google Scholar]
  23. Stevenson R. E., Burton O. M., Ferlauto G. J., Taylor H. A. Hazards of oral anticoagulants during pregnancy. JAMA. 1980 Apr 18;243(15):1549–1551. [PubMed] [Google Scholar]
  24. Sutherland J. M., Glueck H. I., Gleser G. Hemorrhagic disease of the newborn. Breast feeding as a necessary factor in the pathogenesis. Am J Dis Child. 1967 May;113(5):524–533. doi: 10.1001/archpedi.1967.02090200056003. [DOI] [PubMed] [Google Scholar]
  25. Tripp J. H., McNinch A. W. Haemorrhagic disease and vitamin K. Arch Dis Child. 1987 May;62(5):436–437. doi: 10.1136/adc.62.5.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. WEFRING K. W. Hemorrhage in the newborn and vitamin K prophylaxis. J Pediatr. 1962 Nov;61:686–692. doi: 10.1016/s0022-3476(62)80339-4. [DOI] [PubMed] [Google Scholar]
  27. van Doorm J. M., Muller A. D., Hemker H. C. Heparin-like inhibitor, not vitamin-K deficiency, in the newborn. Lancet. 1977 Apr 16;1(8016):852–853. doi: 10.1016/s0140-6736(77)92795-7. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES